MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
206.95
+0.04
+0.02%
After Hours: 208.00 +1.05 +0.51% 19:59 12/31 EST
OPEN
206.91
PREV CLOSE
206.91
HIGH
207.50
LOW
206.37
VOLUME
4.08M
TURNOVER
--
52 WEEK HIGH
215.19
52 WEEK LOW
136.50
MARKET CAP
498.60B
P/E (TTM)
19.97
1D
5D
1M
3M
1Y
5Y
1D
Want Decades of Passive Income? 2 Stocks to Buy Right Now
The Motley Fool · 13h ago
Interesting JNJ Put And Call Options For February 2026
NASDAQ · 12/31/2025 16:12
3 Best ETFs to Invest In, According to AI Analyst, 12/31/2025
TipRanks · 12/31/2025 15:03
Wall Street Analysts Think Johnson & Johnson (JNJ) Is a Good Investment: Is It?
NASDAQ · 12/31/2025 14:30
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock
NASDAQ · 12/31/2025 14:00
Best Dividend Aristocrats For January 2026
Seeking Alpha · 12/31/2025 13:47
Pfizer, GSK and other drugmakers eying U.S. price hikes for 350 medicines: report
Seeking Alpha · 12/31/2025 13:22
BAYRY's 2025 Revival: Will the Momentum Continue in 2026?
NASDAQ · 12/31/2025 13:10
More
About JNJ
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.